EIGR - Eiger BioPharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 5/29/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.12
52-Week Change 314.73%
S&P500 52-Week Change 310.93%
52 Week High 315.82
52 Week Low 34.55
50-Day Moving Average 39.95
200-Day Moving Average 310.83

Share Statistics

Avg Vol (3 month) 3387.46k
Avg Vol (10 day) 3318.44k
Shares Outstanding 525.06M
Float 20.84M
% Held by Insiders 11.70%
% Held by Institutions 185.05%
Shares Short (May 14, 2020) 4769.45k
Short Ratio (May 14, 2020) 42.05
Short % of Float (May 14, 2020) 43.14%
Short % of Shares Outstanding (May 14, 2020) 43.07%
Shares Short (prior month Apr 14, 2020) 4732.76k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Mar 22, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-45.24%
Return on Equity (ttm)-145.28%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -65.61M
Net Income Avi to Common (ttm)-68.3M
Diluted EPS (ttm)-2.83
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)77.61M
Total Cash Per Share (mrq)3.1
Total Debt (mrq)32.32M
Total Debt/Equity (mrq)74.78
Current Ratio (mrq)6.14
Book Value Per Share (mrq)1.76

Cash Flow Statement

Operating Cash Flow (ttm)-62.47M
Levered Free Cash Flow (ttm)-36.67M